Investor Presentaiton
Key Milestones targeted for future
Global
Consumer
• Maintain leadership in existing markets through focus on innovative solutions
• Enhance presence in high growth markets
Healthcare
R&D
• Develop more products through expanded R&D team for global markets
Focus on developing complex products across multiple dosage forms
SUN
PHARMA
Regulatory/
Quality
• Ensuring 24x7 compliance to cGMP is imperative for a global business
• Continuously enhance systems, processes, human capabilities to ensure compliance
with global regulatory standards
.
• Ensure resolution of consent decree at Ranbaxy's facilities
Financial
• Target sustainable and profitable growth
• Deliver on the US$ 300 million synergy benefits from Ranbaxy acquisition by FY18
© Sun Pharmaceutical Industries Limited. All Rights Reserved.
53View entire presentation